arrow_back Civic Audit
Share share

Support for World Sickle Cell Awareness Day

The U.S. Senate expresses support for designating June 19, 2025, as World Sickle Cell Awareness Day. The aim is to increase public awareness of the disease, promote research, early detection, and access to treatment. This initiative seeks to improve the quality of life for individuals affected by the disease and their families.
Key points
Increasing awareness of sickle cell disease in the U.S. and globally.
Supporting research, early detection, and new treatment methods.
Striving for equitable access to innovative therapies for all social groups.
Calling for the elimination of barriers to treatment access within Medicare and Medicaid systems.
Encouraging the creation of educational programs and events about the disease.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_SRES_292
Sponsor: Sen. Booker, Cory A. [D-NJ]
Process start date: 2025-06-18
System Note: Lustra is free, publicly auditable civic infrastructure — full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source—always verify them if you can.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_SRES_292.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-06-18.

What are the main provisions?

Key points include:

  • Increasing awareness of sickle cell disease in the U.S. and globally.
  • Supporting research, early detection, and new treatment methods.
  • Striving for equitable access to innovative therapies for all social groups.
  • Calling for the elimination of barriers to treatment access within Medicare and Medicaid systems.
  • Encouraging the creation of educational programs and events about the disease.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Booker, Cory A. [D-NJ].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

What is the impact of this bill?

We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health